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background:  Nearly 60% of dual-chamber (DC) ICDs are implanted in patients without atrial pacing needs. This decision is largely based 
on improved detection of atrial arrhythmias but carries with it increased complications and mortality over single-chamber ICDs. A new 
single-chamber ICD with atrial sensing (DX) was approved by the FDA in February 2013. This ICD has the potential advantages of single-
chamber models, but with the ability to sense atrial arrhythmias. It is unclear how the DX compares to DC ICDs in a real-world setting.
Methods:  A retrospective cohort study was performed comparable patients with DX or DC ICDs at Einstein Medical Center from 
01/01/2011 to 12/31/2013. Demographic and clinical information, ICD indication, duration of implantation, baseline implantation parameters, 
and acute complications were collected. Student t-tests were used to compare linear data between groups.
results:  Twenty one patients with DX and 12 patients with DC were included. The groups were comparable in terms of patient age at 
implant (DX 54.2±13.6 vs. DC 58.2±20.7 years p=NS). DX patients had a significantly worse LVEF (31.5±15.1% vs. 43.7±15.9% p = 0.03). 
Implant time was considerably shorter for DX patients (35.9± 10.4 vs. 49.7±13.3 minutes; p = 0.002). Atrial sensing at implantation (DX 
4.0±2.1mV vs. DC 3.1±2.6mV) and 6 months (5.5±2.4mV vs. 5.1±2.7mV) were not significantly different between the two groups. The rates 
of atrial arrhythmia detection were also comparable (19% vs. 8% p=NS). There were no acute complications in both groups.
Conclusion:  The DX compares favorably to the DC ICD in terms of sensing and arrhythmia detection and holds the advantage of 
significantly lower implant time and less implanted hardware. Long-term data will be needed to see if these advantages result in lower 
mortality over the DC ICD. The DX is a good alternative to the DC ICD in patients not requiring atrial pacing.
